🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We help pharma, biotechs and CROs optimize their clinical trial and research objectives. Visit us at stand 9 to learn how. #ClinicalTrials #OCTWestCoast

At Avantor, we collaborate with biotech and biopharma customers as they expand their clinical trials, scale up production and prepare for commercialization. One of our hubs for this collaboration is our Innovation Center in Bridgewater, N.J. ow.ly/ssfJ50QyiWB

Don’t let costly delays and disruptions interrupt your #GeneTherapy project. Our flexible, responsive approach safely accelerates your #manufacturing process using a secure supply of qualified, high-purity chemicals and sterile fluid transfer systems.

Today, we reported our fourth quarter and full year 2023 business results. For more information, including our press release and presentation, visit ow.ly/ToUb50QB83T

Our Global Head of Sustainability, Rachel Kaufman, detailed how Avantor successfully established our climate goals during a GreenBiz Group panel this week.

Looking for efficiency in your lab? We help scientists drive insightful and efficient decisions with lab services and digital solutions. Find us at Lab of the Future at Stand 17 in early March. lab-of-the-future.com/USA #LaboftheFuture #lotfUSA2024

What does 2024 hold for biopharma? When Scrip asked Nandu Deorkar, our SVP of biopharma production R&D, how technology will transform biopharma, he identified manufacturing as likely to benefit from AI this year.

Innovative technologies and advancements are shaping the logistics industry and transforming supply chains. Heiko Kritzer presented Avantor’s innovated technologies powering our Bruchsal, Germany facility at #CID24 hosted by CMC. youtube.com/watch?v=YFTKDY…

Today we’re recognizing International Women's Day in honor of women around the world, and especially our female associates and allies who work so hard to help our customers advance scientific innovation. #InspireInclusion #InternationalWomensDay

Did you know that silicone has a 60-year track record of biocompatibility and safety, making it an ideal choice for medical devices such as long-term implants? Learn more: ow.ly/yLY950QR6cb #MedTech #MedicalDevices #BiomedicalEngineering #SiliconeTechnology

Discover how biopharma manufacturer and critical material supplier collaboration can ensure consistent quality of raw materials — minimizing supply chain risk and protecting patient safety. #DCATweek #DCAT2024 #Pharma

Monoclonal antibodies are powerful tools for fighting diseases that require complex and costly manufacturing processes. Optimize your scale-up strategy to your exact needs. #mAbs

Gene therapies hold remarkable promise to treat patients in need. However, the complex manufacturing process can be disrupted if a single piece of equipment is in short supply. Use reliable product alternatives to prevent production delays. ow.ly/JBni50SzYR8

Today, Avantor reported our second quarter 2024 results. Our President and CEO, Michael Stubblefield, and EVP & CFO, R. Brent Jones, discuss our results. For more information, including our press release and presentation, visit ow.ly/x3WC50SL5Z9.

This week, Avantor is showcasing scalable fluid handling innovations at #INTERPHEX2025! Our latest technologies help biomanufacturers drive scalability, flexibility, and efficiency in biologics production. Read more: ow.ly/lMfe50VtqA4

Today, we shared our operating results for the most recent quarter and outlook for the remainder of 2025. See the results: ow.ly/N8Qr50VHKg3

Avantor announces CEO transition. Michael Stubblefield will step down as Director, President & CEO upon appointment of a successor. We thank him for over a decade of leadership. The Board has begun a search for our next CEO. ow.ly/CK1P50VHUNZ

Avantor will participate in the Bank of America Securities 2025 Health Care Conference to highlight how our solutions fuel innovation across life sciences and healthcare. ow.ly/nzUN50VM1bj

Our EVP & CFO, Brent Jones, will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on May 20 at 8:00 a.m. ET. ow.ly/mmOo50VTUH3

How are senior leaders from @Avantor_news, Eli Lilly and Company, and Insilico Medicine advancing lab modernisation in biosciences? Join the FT and Avantor on 18 June for expert analysis on data, automation, and innovation at scale. Register at: bit.ly/3SmR1JT #BIO2025